Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Harbour Investments Inc.

Harbour Investments Inc. decreased its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 16.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 465 shares of the biotechnology company’s stock after selling 92 shares during the period. Harbour Investments Inc.’s holdings in Axon Enterprise were worth $276,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the business. Geode Capital Management LLC raised its holdings in Axon Enterprise by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock valued at $710,103,000 after acquiring an additional 35,320 shares during the last quarter. Westfield Capital Management Co. LP raised its holdings in Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after acquiring an additional 127,769 shares during the last quarter. Champlain Investment Partners LLC raised its holdings in Axon Enterprise by 13.9% in the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after acquiring an additional 83,265 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Axon Enterprise by 1.6% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after acquiring an additional 9,090 shares during the last quarter. Finally, Groupama Asset Managment acquired a new stake in shares of Axon Enterprise during the 3rd quarter worth approximately $200,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Activity

In related news, insider Jeffrey C. Kunins sold 1,035 shares of Axon Enterprise stock in a transaction on Monday, December 23rd. The shares were sold at an average price of $624.47, for a total transaction of $646,326.45. Following the sale, the insider now directly owns 124,243 shares in the company, valued at $77,586,026.21. This trade represents a 0.83 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the sale, the director now owns 1,627 shares in the company, valued at $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 1,792 shares of company stock worth $1,087,843. 5.70% of the stock is currently owned by corporate insiders.

Axon Enterprise Price Performance

Shares of AXON opened at $560.00 on Friday. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The firm’s fifty day simple moving average is $591.90 and its 200-day simple moving average is $540.96. The firm has a market capitalization of $42.91 billion, a price-to-earnings ratio of 144.70, a PEG ratio of 5.17 and a beta of 1.12. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Analyst Ratings Changes

A number of brokerages have recently issued reports on AXON. Craig Hallum downgraded shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. Northcoast Research downgraded shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. The Goldman Sachs Group raised their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. TD Cowen began coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target for the company. Finally, JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $604.67.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.